Hotgen(SH:688068) Xin Lang Cai Jing·2025-09-10 03:05Group 1 - The core point of the news is that Beijing Hotgen Biotech Co., Ltd. experienced a stock decline of 5.28%, with a current share price of 180.81 yuan and a total market capitalization of 16.763 billion yuan [1] - The company, established on June 23, 2005, specializes in the research, development, production, and sales of in vitro diagnostic reagents and instruments, with its main revenue sources being testing reagents (70.87%), testing instruments (19.79%), others (8.17%), and biological raw materials (1.17%) [1] Group 2 - From the perspective of fund holdings, Guotou Ruijin Fund has a significant position in Hotgen Biotech, with its fund holding 13,400 shares, representing 1.12% of the fund's net value, making it the third-largest holding [2] - The fund, Guotou Ruijin SSE Sci-Tech Innovation Board 200 Index Initiation A (023518), has a current scale of 70.0747 million yuan and has achieved a return of 27.69% since its inception on March 18, 2025 [2] - The fund managers, Zhao Jian and Qian Han, have different tenures and performance records, with Zhao Jian having a tenure of 11 years and 351 days and a best return of 172.91%, while Qian Han has a tenure of 2 years and 26 days with a best return of 32.43% [2]